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ABSTRACT Relative differences in the active site environment of a monoclonal antibody when covalently bound to two isomeric
haptens were studied using fluorescence quenching and lifetime measurements. Murine monoclonal antibody 4-4-20, a
well-characterized high affinity antifluorescein antibody, served as the model IgG protein. Isomeric haptenic probes comparatively
studied were fluorescein-5-isothiocyanate (FITC 1, the immunogen) and fluorescein-6-isothiocyanate (FITC 11). In kinetic binding
studies, the association rate for the interaction of 4-4-20 with FITC I was >2,000 times faster than the reaction with FITC 11.
Fluorescence lifetimes for FITC covalently bound to 4-4-20 were 3.89 ns and 0.37 ns, indicative of hapten bound outside and
inside the active site, respectively. Fluorescence lifetime for FITC 11 within the active site was indistinguishable from bound FITC 1,
indicating that interactions with active site residues which resulted in a decreased lifetime were similar for both isomers. A
decreased lifetime for active site bound FITC was consistent with the 90-95% quenching of fluorescein fluorescence. Dynamic
fluorescence quenching experiments with iodide and FITC I in the active site showed no solvent accessibility, whereas bound FITC
11 showed significant accessibility. These results suggest that the difference in bond angle which accompanies binding of isomer 11
relative to isomer I within the active site probably leads to steric constraints resulting in a more open configuration of the 4-4-20
active site.
INTRODUCTION
In pursuit of a better understanding of antigen binding
properties exhibited by immunoglobulin products of
humoral immune responses, and in particular the deter-
mining factors in high affinity, attention has focused on
understanding the nature and environment of the anti-
body active site. Because naturally occurring immuno-
gens are often complex macromolecules, whose struc-
ture and conformation are usually not well defined, it
has been difficult to ascertain critical factors involved in
such antigen-antibody interactions. For this reason hap-
ten systems, in which the antigen is usually a relatively
small compound (mol wt < 1,000) of defined structure,
serve as valuable experimental tools.
Haptens can be judiciously selected to provide desired
properties such as immunogenicity, size, aromatic and/or
ionic character, and observable spectral or even chiral
properties. Because fluorescence measurements are sen-
sitive and reflect the fluorophore's microenvironment,
fluorescent haptens have become important probes. In
addition to intensity measurements, one measurable
fluorescence parameter which provides useful informa-
tion is the fluorescence (or excited-state) lifetime. Rele-
vant biological events which occur on the timescale of
fluorescence lifetime (picoseconds to hundreds of nano-
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seconds) include molecular rotation and interactions
with solvent molecules and neighboring residues (1).
Fluorescence measurements provide an intrinsic sen-
sitivity to monitor the environment surrounding the
fluorophore and has led to extensive use of fluorescence
to establish existence of multiple conformational states
in proteins (1). When applied to small proteins such
measurements have generally utilized the intrinsic fluo-
rescence of a single tyrosine or tryptophan residue per
macromolecule. Application of fluorescence lifetime
measurements to analyses of single tryptophan contain-
ing proteins has been described in detail in a series of
papers by Alcala et al. (2-4) and Beechem and Brand
(1). Antibody molecules are relatively large macromole-
cules (150 kD) which contain multiple tyrosine and
tryptophan residues negating the application of this
approach. To avoid this restriction, it is often necessary
to utilize extrinsic fluorescent probes. Consistent with
this rationale the fluorescein:antifluorescein system, in
which fluorescein is both the antigen and an extrinsic
fluorescent probe, has become an important model
system to derive information concerning the microenvi-
ronment of the antibody active site (5).
This work employed fluorescence measurements to
probe the active site of monoclonal antifluorescein
antibodies. When conjugated to an appropriate carrier,
fluorescein is a potent epitope which elicits a diverse
immune response in several species, including signifi-
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cantly high affinity antibodies (6). Spectral properties of
fluorescein, which make it a useful probe, include
absorbance in the visible region of the spectrum (493
nm), a reasonable extinction coefficient (72,000 M1
cm-1), excitation and emission maxima (493 and 525 nm,
respectively) which do not overlap with intrinsic protein
fluorescence (350 nm), and a large quantum yield
( > 90%). Spectral shifts in absorbancy and quenching of
fluorescence upon antibody binding of fluorescein pro-
vide information regarding mechanisms involved in
ligand binding (5).
A homogeneous antifluorescein antibody used in this
work was the high affinity (1-2 x 10" M-') murine
monoclonal antibody (Mab) 4-4-20. Mab 4-4-20 has
undergone extensive characterization in terms of spectro-
scopic and binding properties (7) as well as primary
structure (8). In addition the three-dimensional crystal
structure has been solved for the 4-4-20-fluorescein
complex (9, 10). Recently, Mab 4-4-20 served as a model
protein in the direct observation of immunoglobulin
adsorption dynamics using the atomic force microscope
(11).
Studies reported include absorbance measurements
and fluorescence lifetime and quenching measurements
of Mab 4-4-20, N-acetyl-L-lysine and normal mouse IgG
covalently labeled with fluorescein-5-isothiocyanate
(FITC I) or fluorescein-6-isothiocyanate (FITC II).
Although Mab 4-4-20 is referred to generically as an
antifluorescein antibody, it is more precisely antiFITC I
because the original immunogen was synthesized using
fluorescein-5-isothiocyanate. Thus, availability of the
same spectral probe (fluorescein) in isomeric forms
provided a unique opportunity to couple with sensitive
fluorescent measurements in a comparative study of the
homologous isomer (I) and a cross-reactive isomer (II).
Affinity labeling with FITC isomers I and II provided
two active site probes with identical spectral properties
but with the potential to bind differently within the
active site. It was the goal of this work, based on two
isomers of the same ligand, to provide information that
contributes additional insight into the chemical nature,
conformation, and dynamics of the antibody active site.
MATERIALS AND METHODS
Cell line
Hybridoma cell line 4-4-20 was obtained by chemical fusion of the
nonsecreting murine myeloma cell line Sp2/0-Ag 14 with splenocytes
from an inbred colony of BALB/cV mice hyperimmunized with
fluorescein isothiocyanate isomer I (FITC I) conjugated to keyhole
limpet hemocyanin (KLH) and emulsified in complete Freund's
adjuvant as described by Kranz et al. (12) using the method of Galfre
et al. (13).
Production of monoclonal antibody
protein
Mab 4-4-20 was produced in serum free media in an airlift bioreactor
(14). After removal of cells and concentration of extracellular media,
the antibody was purified using preparative protein-A affinity chroma-
tography (14). Immunoglobulin purification was accomplished by
dextran sulfate precipitation of serum lipoproteins and ammonium
sulfate precipitation of the gamma globulin fraction followed by
DEAE-cellulose ion-exchange chromatography at pH 7.4. Affinity
purification with a Fl-adsorbent was avoided because acid or high salt
elutions of Mab 4-4-20 resulted in release of some ligand (from the
adsorbent) which was difficult to quantitatively remove due to tight
binding. Mab 4-4-20 has an intrinsic affinity (K.) of 1-2 x 1010 M` and
consists of kappa (K) light and gamma (y) 2a heavy chains. A red shift
in the wavelength of maximum absorbance (X m,ux) of fluorescein from
493 to 508 nm and a maximum quenching of the fluorescence of
fluorescein (Qm,Ax) of 96.4% upon binding of fluorescein by 4-4-20 has
been reported (6, 7).
Normal mouse IgG
Young nonimmunized mice were bled as a source of normal IgG to be
used as a control reagent. Immunoglobulin purification was accom-
plished by dextran sulfate precipitation, ammonium sulfate precipita-
tion, and diethylaminoethyl (DEAE) cellulose chromatography as
previously described.
Ig sample preparation
For labeling reactions, IgG was diluted to 1 mg/ml with buffer. FITC
labeling reactions were performed by adding appropriate amounts of
10' M FITC (Molecular Probes, Inc., Eugene, OR) in absolute
ethanol to 1-2 ml of the diluted immunoglobulin (corresponding to
13.3 pJ of 10' M FITC in 2 ml of IgG at a concentration of 1 mg/ml).
Samples were incubated at room temperature for 2-3 h and dialyzed
extensively (minimum of six buffer changes over three days) against 50
mM Tris(tris[hydroxymethyl]-aminomethane), 150 mM sodium chlo-
ride (TBS) buffered at pH 8.3.
FITC-N-acetyl-L-lysine was prepared by incubation of N-acetyl-L-
lysine with excess FITC (I or II) in carbonate buffer for 2-3 h.
FITC-N-acetyl-L-lysine was purified by preparative TLC on silica gel
using methylethylketone saturated with acetate buffer (pH 5.0) as the
solvent. A visible band containing fluorescein labeled N-acetyl-L-lysine
was harvested from the plate and solubilized in buffer.
Instrumentation
A model 8450A (Hewlett-Packard Co., Palo Alto, CA) Diode Array
spectrophotometer was used in absorbance measurements. Fluores-
cence intensity measurements were performed on a photon counting
spectrofluorometer (Gregg-P.C., ISS Instruments, Champaign, IL)
using a xenon arc lamp with excitation at 493 nm and emission at 530
nm. A 520 nm cut-on filter was used to select emission wavelengths
>520 nm. Fluorescence lifetimes were measured on the multifre-
quency phase fluorometer described by Gratton and Limkeman (15)
using the 442 line of a HeCd laser and an acousto-optic modulator as
described by Piston et al. (16). A 440 nm bandpass filter was used for
excitation and 520 nm cut-on filter was used for emission. Measure-
ments were taken using a scatter solution of glycogen as a reference.
Phase and modulation data were collected using 8-12 frequencies
ranging from 1 to 150 MHz.
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Association rate assays
Second-order association rates of FITC I and II binding to Mab 4-4-20
were determined by monitoring the decrease in fluorescence intensity
as a function of time after mixing (17). Equal volumes of 4-4-20 and
FITC were mixed using a manual stopped flow apparatus (Hi-Tech
Scientific model SFA-II Rapid Kinetics Assembly, Hi-Tech Scientific,
Wilts, England) thermostated at 2°C. Based on the concentration of
FITC used (2.0 x 10' M), slightly more than a 10-fold molar excess of
4-4-20 (2.7 x 10' M IgG) ensured first order kinetics. Fluorescence
intensity measurements were taken as a function of time using kinetics
software (ISS Inc., Champaign, IL). Data were saved as ASCII files
and converted to comma separated variable (CSV) files for use with
OnRate analysis software (University of Illinois at Urbana-Cham-
paign, Urbana, IL). The technical rate constant (Ktc,h) was determined
from the slope of the plot of the fraction free ligand (LIL.) as a
function of time (t). The fraction free ligand was calculated using the
equation
F(t) - F(eq)
lnF(0) F(eq)'(1
where F(t) is the fluorescence intensity at time t, F(eq) is the
equilibrium fluorescence intensity, and F(O) is the initial fluorescence
intensity. The bimolecular quenching constant (K,) was calculated
using the equation
fb(eq) X KI.ch
K, = (2)
wherefb(eq) is the fraction of bound ligand at equilibrium, [sites] is the
concentration of active sites, and K,cch is the slope of the plot ofLILo vs.
t. Experiments were repeated at least in triplicate.
Fluorescence lifetime measurements
Lifetime measurements were taken (room temperature) until the
error in the phase angle was less than or equal to, 0.20 and the
modulation ratio less than or equal to 0.01.
Lifetime analysis
Analysis of multifrequency phase and modulation data was performed
on a personal computer using the Global Unlimited analysis software
described by Beechem and Gratton (18). Data were analyzed using
different fitting routines and in all cases the best fit was obtained for a
two discrete component exponential decay.
Iodide quenching
Fluorescence quenching studies with iodide were performed as de-
scribed by Watt and Voss (19).
RESULTS AND DISCUSSION
Affinity labeling control reactions
Affinity labeling of Mab 4-4-20 with FITC (I or II)
involved covalent conjugation of the isothiocyanate group
in the antibody active site. Crystal data defining the
4-4-20 three-dimensional structure have indicated that
the most likely site of FITC I attachment is lysine
residue 52b of the heavy chain (8, 10). Characterization
studies of free FITC and FITC covalently attached
N-acetyl-L-lysine and normal mouse IgG were used to
differentiate active site effects from those caused by
covalent binding of FITC to L-lysine, or nonactive site
lysyl residues.
Absorbance measurements
A parameter denoting fluorescein binding by Mab 4-4-20
is a characteristic bathochromic shift in the maximum
absorbance (K.) by bound ligand. To determine rela-
tive spectral shifts, absorbance measurements were
performed with FITC I and II free in solution and
covalently bound to N-acetyl-L-lysine, normal mouse
IgC, and Mab 4-4-20 (Table 1). Because wavelength
resolution limits of the absorbance spectrophotometer
were 1 nm in the ultraviolet range and 2 nm in the visible
range, absorbance values obtained are + 1 nm for
antibody and +2 nm for FITC.
No differences were observed in XAMA) either between
the two FITC isomers, FITC free in solution or conju-
gated to N-acetyl-L-lysine. Thus, there were no inherent
spectral differences between the FITC isomers and
formation of the thiocarbamyl linkage (isothiocyanate
group and the c-amino group of a lysine residue) did not
result in a spectral shift. FITC I bound to normal mouse
IgG exhibited a small spectral shift (4-6 nm) and labeled
with an efficiency of 40%. Mab 4-4-20 was labeled in
TABLE 1 Comparative absorbance values for FITC
Isomers I and 11
Sample X.. A mX. A278 Eff a
FITC I 488 0.12
FITC II 488 0.11
N-Acetyl-L-Lysine
FITC I 490 0.10 -
FITC II 490 0.11 -
Normal mouse IgG
FITC I 494 0.41 1.81 0.71 0.36
FITC II 494 0.32 1.23 0.82 0.41
4-4-20
FITC I (lx)' 506 0.26 0.84 0.98 0.49 508
FITC II (lx)' 502 0.08 0.91 0.27 0.13 506
FITC I (100x)' 504 0.56 0.84 2.08 0.01 508
FITC II (0.lx)' 506 0.04. 0.81 0.15 0.77 508
*After subtraction of contribution by FITC (pH 8.3). *The number of
FITC molecules per antibody. 'Binding efficiency. IDetermined by
spectral subtraction of normal mouse IgG labeled with FITC. The
same values were obtained for spectral subtraction of FITC free in
solution. 'Denotes molar equivalent of FITC reacted with the anti-
body.
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the presence of a molar equivalent of FITC I (referred
to as lx) based on the number of antibody active sites
and possessed a Xx of 506 nm. This was close to the
maximum shift expected and indicated that essentially
all FITC I was bound within the active site. Labeling
efficiency for the reaction was 49%. Mab 4-4-20 labeled
lx with FITC II in a parallel reaction had a Xx of 502
nm and a labeling efficiency of 13%.
In assessing effects of FITC binding outside the active
site on the absorbance spectrum, Mab 4-4-20 was re-
acted with a large excess of FITC I (lOOx molar equiva-
lents of active sites). After extensive dialysis, the result-
ing absorbance spectrum contained a single averaged
Xx at 504 nm. This indicated that the X. of 502 nm
obtained for 4-4-20 labeled with FITC II represented an
average value.
To determine a more accurate value of Xmx for FITC
II within the active site, binding outside the active site
was minimized by labeling 4-4-20 with 1/10 a molar
equivalent of FITC II. The Xmx for this sample was 506
nm, the same as that obtained for 4-4-20 labeled with a
molar equivalent of FITC I. Thus, all FITC II was bound
within the active site and there were no differences in
the spectral shifts for FITC I and II when bound within
the 4-4-20 active site. Therefore, the XAX of 502 nm
obtained for 4-4-20 labeled lx with FITC II was the
result of significant binding external to the active site.
To confirm that the AXx of FITC II within the 4-4-20
active site was the same as FITC I, spectral subtractions
were performed. Because the percentages of FITC
within and outside the active site were not known, a
relatively simple approach was taken. Absorbance of
FITC bound to 4-4-20 at 494 or 496 nm (for FITC I and
II, respectively) was matched with the absorbance of
FITC I or II bound to normal mouse IgG at 494 or 496
nm. The absorbance spectrum charactizing FITC bound
to normal mouse IgG was subtracted from the appropri-
ate spectrum of 4-4-20 labeled with FITC. The same
method was used to subtract the spectra of free FITC I
or II from the spectrum of 4-4-20 labeled with FITC. In
both cases, the resultant spectra showed a Xmx of 508
nm for 4-4-20 labeled lx and lOOx with FITC I and O.lx
with FITC II. The Xmx for 4-4-20 labeled lx with FITC
II was 506 nm. Because resolution in this region was ±2
nm, subtraction of contributions from FITC bound
outside the active site of 4-4-20 resulted in the same
spectral shift in all cases (508 + 2 nm). This provided
further evidence that there were no detectable differ-
ences in the environment of FITC I and II within the
4-4-20 active site.
Absorbance data indicated that although there was a
100-fold difference in the amount of FITC I used to label
Mab 4-4-20 in the two labeling experiments (lx and
lOx), there was only a twofold increase in the amount of
FITC I bound to 4-4-20. Because the spectral shift was
only 2 nm less than that obtained for 4-4-20 labeled lx
with FITC I, and the r value was only slightly greater
than two (all active sites liganded) it appeared that little
FITC I was located outside the active site. Because
labeling efficiency for normal mouse IgG was 40%,
this suggested that upon FITC I binding within the
active site additional binding of FITC outside the active
site became increasingly difficult. This may result from
domain tightening in the antibody upon FITC binding
(20). Failure to label outside the active site may also
correlate with the relative rates of hydrolysis of the label
(at the concentrations of reagent used) in comparison to
the rate at which adducts are formed between FITC and
multiple lysine residues.
Association rate analysis
The association rate for FITC I binding with Mab 4-4-20
(data not shown) was determined to be 10.80 + 1.13 x
106 M-'s-1 (average of five trials) which is a factor of two
higher than that obtained by Herron (17). The maximum
amount of FITC I bound ranged from 98 to 99%.
Association kinetics describing binding of FITC II to
4-4-20 were determined to contain a fast and slow
component with rates of 5.01 + 0.23 x 103 and 1.92 +
0.04 x 103 M-'s-1, respectively. Associations rates for
FITC II were the result of three trials, and the maximum
amount of FITC II bound was 92.5%.
Since for even the fast component, binding of FITC II
by 4-4-20 was more than 2,000 times slower than that
observed for FITC I, it appeared that the difference in
the position or orientation of the isothiocyanate group
must result in significant steric hindrance to binding
within the active site of 4-4-20. The latter accounted for
the decreased binding of FITC II within the 4-4-20
active site observed in absorbance measurements.
Lifetime measurements
Phase and modulation data for FITC I and II free in
solution and covalently bound to N-acetyl-L-lysine, nor-
mal mouse IgG, and Mab 4-4-20 were fit to models
containing one to three discrete lifetimes using Globals
Unlimited (18). FITC I and II displayed a 3.86 and 1.33
ns components free in solution and bound to N-acetyl-L-
lysine and normal mouse IgG. When bound within the
active site of Mab 4-4-20, FITC I and II were found to
have a short-lived component due to fluorescence
quenching of FITC within the active site. Chi-square
values (x2, Table 2), decreased significantly when the
number of lifetimes in the model increased from one to
two. For some samples, the x2 values reported for a two
component fit actually represented a three component
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TABLE 2 Global analysis chi-square values for discrete and distributed lifetime models
Discrete Distributed
Single Double Triple Single Single
Sample exponential exponential exponential Lorentzian Gaussian uniform
FITC I 90.0 0.9* 1.4 2.2 3.6
FITC II 65.7 2.7* 3.2 4.6 5.2
N-Acetyl-L-Lysine
FITC I 44.7 1.1* 0.9t 1.4 1.4 2.9
FITC II 53.5 1.3 0.8t 1.8 2.1 4.3
Normal mouse IgG
FITC I 130.5 2.1 0.4 4.3 1.8 5.7
FITC II 116.6 0.8 0.9 5.0 1.3 3.6
4-4-20
FITC I (1x)l 788.4 1.6 1.9 35.5 308.3 457.1
FITC II (lx)' 783.8 1.9* 23.3 4.1 7.5
FITC I (10x)' 589.1 0.8 0.9 8.0 162.1 275.4
FITC II (0.1x)' 1006.1 1.4* 25.9 205.1 378.1
FITC I (100x)' 213.9 2.1 2.2 24.3 4.1 12.7
*All numbers stated are chi-square values. A three component fit in which the third component had a long lifetime and was derived from less than
one percent of the fluorescent species. 'This fit gave a small percentage of a long-lived component. 'Denotes molar equivalent of FITC reacted with
the antibody.
fit in which the third component had a long lifetime and
was derived from <0.5% of the species (Table 2).
Because the fluorescence lifetime was relatively long
and the amount of that species present small, the third
component was thought to be either a contaminant or an
instrumental artifact not directly attributable to FITC.
Therefore, a two component fit was considered appropri-
ate.
To determine whether the fluorophore population
contained two discrete lifetimes or a single distributed
lifetime, data were fit to models for Lorentzian, Gaus-
sian, and uniform distributed lifetimes (Table 2). FITC I
and II free in solution and covalently bound to N-acetyl-
L-lysine and normal mouse IgG, fit two discrete lifetimes
only slightly better than for a single Lorentzian or
Gaussian distribution but significantly better than in an
uniform distribution. However, for Mab 4-4-20 affinity
labeled with FITC, two discrete lifetimes fit the data
2-30 times better than the best fit obtained for a
distributed lifetime. Because two discrete lifetimes were
found to best fit the data, all further analyses were
performed using the two discrete lifetimes model.
Lifetime resolved fluorescence
quenching
Quenching studies were performed on samples listed in
Table 2 as a means of assessing ligand (FITC) accessib-
lity to iodide in each sample as well as a means of
providing data sets to establish confidence intervals. For
each sample, phase and modulation measurements were
taken from 2 to 150 MHz for 5-6 different quencher
concentrations (ranging from 0-0.3 M KI). Data sets
were analyzed using Globals Unlimited and fit to two
discrete lifetimes and two quenching constants and for
comparison with one lifetime and one quenching con-
stant. For each data set, lifetime and quenching con-
stants were linked and the mole fractions varied. All
results and confidence intervals obtained are summa-
rized in Table 3. The data were clearly best fit by a two
component, two quenching constant model.
Error analysis
Confidence intervals reported in Table 3 were deter-
mined by performing error analyses on data sets using
Globals Unlimited. A complete minimization was per-
formed for each fixed value of the tested parameter.
Errors were calculated using the maximum allowable
error in phase (+0.20) and modulation (±0.01). Confi-
dence intervals reflect the minimum and maximum
values of the lifetime or quenching constant for which x2
falls below the 67% confidence interval (1 SD).
Fluorescence lifetimes
FITC I and II free in solution were both found to possess
3.86 0.16 and 1.33 + 0.24 ns lifetime components
(Table 3). Both lifetimes were obtained for FITC
covalently bound to N-acetyl-L-lysine and normal mouse
Swindlehurst and Voss Fluorescence Measurements of Mab 4-4-20 623Swindlehurst of 4-4-20 623
TABLE 3 Global analysis of phase and modulation lifetime and quenching data
One r,
Two discrete exponential lifetimes and two quenching constants OneK
Sample
FITC I
FITC II
N-Acetyl-L-Lysine
FITC I
FITC II
Normal mouse IgG
FITC I
FITC II
4-4-20
FITC I (lx)
FITC II (lx)
FITC I (10x)
FITC II (0.lx)
FITC I (100x)
fi* T' (ns)
0.66 3.86 0.16
0.66 3.53 0.34
K1 (M-')
2.30 + 0.22
2.25 t 1.79
A* T' (ns)
0.34 1.33 0.24
0.34 1.18 ± 0.71
0.75 4.14 ± 0.31 2.18 ± 0.34 0.25 1.74 ± 0.46
0.73 3.97 ± 0.18 2.07 ± 0.23 0.27 1.32 ± 0.35
0.59 3.89 ± 0.22 0.56 ± 0.11 0.41 1.38 ± 0.23
0.59 3.89 ± 0.14 0.57 ± 0.11 0.41 1.28 ± 0.16
0.04
0.35
0.06
0.10
0.13
3.89 + 0.32
3.34 t 0.14
3.72 t 0.42
3.82 t 0.23
2.97 t 0.32
2.08 + 0.39
0.56 ± 0.07
3.05 ± 0.39
0.69 ± 0.25
0.38 ± 0.33
0.96
0.65
0.94
0.90
0.87
0.37 0.03
0.67 0.08
0.44 ± 0.05
0.49 ± 0.04
0.74 ± 0.06
K2 (M-')
3.56 ± 2.17
3.47 ± 3.35
x2 x2
0.62 48.58
1.58 51.59
3.02 + 1.81 1.42 20.70
2.35 2.44 1.08 25.48
1.66 + 0.76 2.71 116.28
1.72 + 1.06 1.56 130.53
-3.01 + 3.40
2.34 ± 0.91
0.68 ± 1.51
1.13 + 1.71
0.77 ± 0.68
1.86
2.28
2.33
1.66
2.23
3877.85
460.11
114.35
624.98
116.03
*Mole fraction (not fractional intensity).
immunoglobulin molecules. Because a normal mouse
antibody population lacks detectable specific antifluores-
cein activity, FITC is most likely bound to lysine residues
external to the immunoglobulin active site. Invariance in
fluorescence lifetime values demonstrated that neither
covalent binding of the FITC molecule nor interactions
of the FITC molecule with residues outside the antibody
active site molecule affect the FITC lifetime. The
percentage of the 3.86 and 1.33 ns components was the
same for FITC I and II and varied only ±+10% when
bound to N-acetyl-L-lysine or normal mouse IgG. Thus,
there was no indication of preferential binding of one
component relative to another. The two lifetime compo-
nents (3.86 and 1.33 ns, Table 3) appeared to be
primarily due to pH 8.3, which was employed based on
the antibody binding experiments. In 0.1 N NaOH,
fluorescein and FITC (I and II) in the dianionic form
showed almost exclusively the 3.86 ns component. Thus,
at pH 8.3 it appears that the monoanionic form of
fluorescein correlates with the 1.33 ns component.
For Mab 4-4-20 labeled with a molar equivalent (lx)
of FITC I, 96% of the FITC molecules were found to
have a lifetime of 0.37 ns and 4% to have a lifetime of
3.89 ns. Absorbance measurements indicated that essen-
tially all FITC was bound within the active site. Kinetic
studies showed that FITC I was bound to the active site
within 15 s at 2°C. Therefore, FITC I was apparently
"pocketed" by the Mab 4-4-20 before it bound outside
the active site. Thus, the 0.37 ns lifetime reflects ligand
within the active site. Quenching of fluorescein bound
within the active site of 4-4-20 has ranged between 90
and 95% (7). It has been suggested that tryptophan, and
in one case histidine residues, are involved in antibody
active site quenching of bound fluorescein (5). X-Ray
crystallographic results revealed that the xanthonyl ring
of fluorescein fits a narrow slot in the 4-4-20 active site,
the bottom of which is formed by tryptophan L101 and
the sides by tryptophan H33 and tyrosine L37 (10). Such
interactions may result in a decreased fluorescence
lifetime of fluorescein within the 4-4-20 site. A decrease
in the lifetime of fluorescein from 3.86 ns outside the
active site to 0.37 ns within the active site is proportional
to fluorescence quenching within the active site. This
suggested that 0.37 ns was a reasonable active site
lifetime for FITC and the observed quenching was
predominantly dynamic. Of the remaining FITC 4% had
a lifetime of 3.86 ns which corresponds to FITC either
free in solution or bound to lysine residues external to
the antibody active site.
When Mab 4-4-20 was labeled with a molar equivalent
(lx) of FITC II, only 65% of the molecules were found
to exhibit a short lifetime. Because only 13% of FITC II
added bound to 4-4-20, this corresponded to 9% of the
FITC II binding within the 4-4-20 active site. Decreased
amounts of FITC II bound within the active site most
likely reflected the slow association rate for binding with
4-4-20, permitting extensive external binding. The fluo-
rescence lifetime of the short component of 4-4-20
labeled lx with FITC II was nearly twice as long as the
lifetime of FITC I within the active site. In addition, the
lifetime of the species outside the active site was 3.34 +
0.14 ns, which was shorter than that observed for FITC
bound to normal mouse IgG (3.89 + 0.14 ns). Because
normal mouse IgG labeled with FITC gave two lifetimes,
624 Biophysical Journal Volume 59 MarchBiophysical Journal Volume 59 March 1991
3.89 and 1.38 ns, one would expect that 4-4-20 labeled
with FITC would have displayed three lifetimes: a 3.89
and a 1.38 ns component corresponding respectively to
FITC bound outside of the active site, and a short lived
component corresponding to FITC within the active site.
Data simulations
Because none of the FITC-labeled Mab 4-4-20 samples
fit the three component model, simulations were per-
formed to determine resolvability of the three lifetimes.
All simulated data were analyzed over the frequency
range of 1-160 MHz and 1 MHz-1 GHz. In the first
simulation, the data were analyzed over a frequency
range of 1-160 GHz, and x2 for the three component fit
was not significantly better than x2 for a two component
fit. This confirmed that the data were best fit by a two
component model.
In the second simulation, which represented Mab
4-4-20 labeled lx with FITC II, similar trends were
evident. Simulated data analyzed over a range of 1-160
MHz in a three component fit gave only a slightly better
x2 than the two component fit. In the two component fit,
the long component was determined to have a shorter
lifetime and the short component to have a significantly
longer lifetime than the simulated value. This was
consistent with data obtained characterizing Mab 4-4-20
labeled lx with FITC II. Thus, the 4-4-20 data could
have been the result of three components with lifetimes
and mole fractions similar to those used in the genera-
tion of the simulated data.
Based on the simulation studies, the two lifetimes
model for FITC (I and II) labeled Mab 4-4-20 would be
consistent with active site amino acid-ligand interactions
revealed by high-resolution crystallographic studies (10).
The two pKa values for free fluorescein are 6.7 and 4.4,
whereas the two values in the bound state are lower.
Thus, the 1.33 ns lifetime indicative of a monoanionic
subspecies of free fluorescein may not exist in the
antibody bound state due to conversion of the 3.86 and
1.33 ns components to a quenched 0.37 ns species. This
suggests that all antibody bound ligand molecules are in
the same ionic state.
Iodide quenching constants
Phase and modulation data, as a function of quencher
concentration, are shown in Fig. 1 a for normal mouse
IgG labeled with FITC I (lx) and in Fig. 1 b for 4-4-20
labeled with FITC I (lx). In the case of normal mouse
IgG, FITC I was covalently attached to lysine residues at
various positions outside the active site. A shift in the
phase and modulation curves to higher frequencies for
FITC bound to normal mouse IgG with increasing
I
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FIGURE 1 Phase and modulation data as a function of quencher con-
centration for FITC I bound to (A) normal mouse IgG and (B) 44-20.
In each case the lower curves correspond to values of phase and the
upper curves to values of modulation. Symbols are as follows: (A) [KI],
in molar: 0, (0); 0.05, (O); 0.10, (V); 0.15, (O); 0.20, (A); 0.30, (+);
(B) [KI], in molar: 0, (0); 0.025, (E); 0.05, (V); 0.10, (0); 0.15, (A).
quencher concentration (Fig. 1 a) showed the accessibil-
ity of FITC to iodide. Fig. 1 b shows only a slight shift to
higher frequencies as a function of quencher concentra-
tion. This indicated that FITC within the active site of
4-4-20 was inaccessible to iodide consistent with previ-
ous findings (7).
Quenching constants (K1 and K2) are summarized in
Table 3. No difference in quenching was found between
FITC isomers I and II, and between FITC free in
solution or bound to N-acetyl-L-lysine. Thus, quenching
of FITC by iodide was unaffected by linkage to lysine.
FITC bound to normal mouse IgG was found to have a
smaller quenching constant than FITC free in solution.
Decreased solvent accessibility may have been due to
FITC binding to nonspecific grooves or pockets on the
surface of the antibody molecule partially shielding it
from solvent. Because the quenching constant for FITC
I within the 4-4-20 active site was essentially zero, it
implied that iodide was excluded. The latter was consis-
tent with the tight fit of fluorescein within the binding
pocket of 4-4-20 as determined by crystallographic data
(10). The quenching constant for FITC I outside the
active site corresponded to the quenching constant for
free FITC rather than FITC bound to normal mouse
IgG.
Mab 4-4-20 labeled lx with FITC II had a relatively
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large quenching constant for the short lived component.
Assuming that the quenching constant contained a
contribution from the species within the active site plus a
contribution from the 1.33 ns component, then it might
be expected that the value of the quenching constant
would be intermediate between 0 and 1.7 M-'. However,
the quenching constant was 2.3 M` which was larger
than the quenching constant obtained for either the 1.33
ns or the 3.86 ns component of normal mouse IgG. For
FITC II labeled O.1x with FITC II, the quenching
constant for the 3.86 ns component was the same as that
obtained for normal mouse IgG.
Stern-Volmer analysis
Because iodide usually quenches primarily by promotion
of intersystem crossing to the triplet state and subse-
quent quenching by other processes, it was anticipated
that quenching of FITC by iodide would be predomi-
nantly dynamic in nature. To determine static or dy-
namic quenching, or a combination of both, plots of the
fraction of fluorescence intensity remaining (F0IF) and
the fractional average lifetime ((T-)/(r)) were made accord-
ing to the Stern-Volmer relationship,
F.IF = 1 + kqTo[Q] = 1 + K,,[Q],
TABLE 4 Quenching constants derived from Stem-Volmer
analyses
Sample Ksv* Kdt Ks'
FITC I 9.27 + 0.97 9.12 ± 0.46 0.63
FITC II 9.71 ± 0.52 9.01 ± 0.31 0.69
N-Acetyl-L-Lysine
FITC I 10.07 ± 0.64 9.75 ± 0.37 0.32
FITC II 9.27 ± 0.59 8.74 ± 0.14 0.53
Normal mouse IgG
FITC I 3.79 ± 0.39 3.10 ± 0.19 0.69
FITC II 3.33 ± 0.38 2.72 ± 0.08 0.61
4-4-20
FITC I (1x)1" 0.80 ± 3.41 0.55 ± 2.45 0.25
FITC II (lx)H 1.82 ± 0.16 1.88 ± 0.13 -0.07
FITC I (lOx)'1 0.69 ± 0.02 2.01 ± 0.16 -1.32
FITC II (O.1x)1 0.35 + 0.75 2.15 ± 0.54 -1.80
FITC I (100x)" 1.59 ± 0.28 1.31 ± 0.40 0.28
*Stern-Volmer quenching constant derived from the slope of FOIF vs.
[Q]. 'Dynamic quenching constant from the slope of ('ro)/(r) vs. [Q].
'Static quenching constant, calculated from K, = K. - Kd. 1Denotes
molar equivalent FITC reacted with Mab 4-4-20.
(3)
where kq is the bimolecular quenching constant and Ksv
the Stern-Volmer quenching constant. Because Ksv
contains contributions from both static (Ks) and dynamic
(Kd) quenching, the slope of a plot of F.IF vs. [Q] is Ksv,
where Ksv = KS - Kd. Because the fractional average
lifetime is related to the quencher concentration by the
equation
(To)/(T) = 1 + Kd[QI,
lL
(4)
the slope of a plot of (¶o)/(T) vs. [Q ] gives Kd, the dynamic
contribution to the quenching constant. Static contribu-
tions to the quenching constant are determined by
taking the difference in the slopes of the plots of F.IF
and (70)/(T) vs. [Q]. Slopes (Table 4) of the plots of F0/F
and (TO) vs. [Q ] showed that quenching of FITC by iodide
was almost entirely dynamic.
The quenching constants followed similar trends as
those obtained for Global analysis of phase and modula-
tion data. Quenching constants measured for FITC
bound to normal mouse IgG were found to be smaller
than those obtained for FITC free in solution or bound
to N-acetyl-L-lysine. Plots of F./F and (T)/(T) vs. [Q] are
shown in Fig. 2 a for FITC I, and in Fig. 2 b for FITC II
bound to normal mouse IgG and 4-4-20.
The difference in quenching of FITC bound outside
the antibody active site relative to within the active site
of a specific antibody is illustrated in Fig. 2 a. Quenching
[Kl]
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FIGURE 2 F0/F vs. [KI], (in molar), for NMIgG ( A ) and 4-4-20
(- A ) and (r.)/(r) vs. [KI], (in molar), for NMIgG (-0-) and 4-4-20
(-0-). Samples are labeled lx with (A) FITC I and (B) FITC II.
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constants for FITC I bound to normal mouse IgG were
3.79 and 3.10 M' for KS, and Kd, respectively. These
values represented quenching constants for FITC bound
outside the antibody active site. For 4-4-20 labeled lx
with FITC I, it had been established that essentially all
(96%) FITC was bound within the active site. As can be
seen in Fig. 2 a, the quenching constants obtained were
small (KSV = 0.80 M` and Kd = 0.55 M-l). Thus, FITC
within the active site was considerably less accessible to
iodide than FITC bound outside of the active site.
As shown in Fig. 2 b, Mab 4-4-20 labeled lx with FITC
II had quenching constants intermediate between those
found for normal mouse IgG and 4-4-20 labeled lx with
FITC I. For 4-4-20 labeled lx with FITC II, 35% of the
FITC was bound outside of the active site and 65%
within the active site. The quenching constants obtained
were 1.82 and 1.88 M` for KSV and Kd, respectively.
These values were about twice those expected assuming
a linear relationship between the percent of FITC
bound outside of the active site and the quenching
constant (KSV = 1.09 M-l, Kd = 0.93 M-1).
Consideration of these data in the context of results
obtained from Global analysis of lifetime resolved
quenching measurements, indicated that the quenching
constant for FITC II within the active site of 4-4-20 was
significantly greater than the constant for FITC I within
the active site. Significant accessibility of FITC II to
iodide when bound within the 4-4-20 active site sug-
gested that the active site existed at least on an average,
in a more open configuration. The latter could be the
result of steric constraints, which either force the active
site into a more open conformation or result in a
broader spectrum of conformational fluctuations of the
active site (relative to binding of FITC I) in an effort to
accommodate the FITC II isomer (20).
CONCLUSION
Suitability of the antifluorescein antibody model is
directly dependent on advantageous spectral properties
of the homologous fluorescein ligand. In particular Mab
4-4-20 has served as a high affinity prototype. In this
report, the active site microenvironment of 4-4-20 has
been studied comparatively when bound to the homolo-
gous ligand and to an isomeric hapten (FITC I and II,
respectively). Results show that the homologous ligand
(isomer I) has an association rate > 2,000 times that of
the isomeric ligand II, probably due to favorable steric
considerations. Once within the active site both isomers
exhibit the same fluorescence lifetimes and degree of
spectral shift, indicating almost identical microenviron-
ments. However, when the isomeric ligand is bound it is
significantly more accessible to solvent than the homolo-
gous ligand, suggesting that 4-4-20 may exist in a more
open configuration.
Based on the three-dimensional crystallographic struc-
ture of the 4-4-20 active site, the planar xanthonyl
moiety of fluorescein fits tightly into a slot near the
bottom of the site (10). Because FITC I is the homolo-
gous ligand and gives identical spectral and fluorescence
properties when bound to 4-4-20, it is reasonable to
assume that the isothiocyanate derivative of fluorescein
fits into the same active site slot. The xanthonyl moiety is
aromatic, planar, highly delocalized, and based on a
favorable alignment with the phenylcarboxyl group plays
a significant role in ligand fluorescence properties.
Because fluorescence lifetimes and spectral shifts were
the same for both isomers, it is likely that the environ-
ment surrounding the xanthonyl moiety is the same for
both isomers when bound within the 4-4-20 active site.
Therefore, although isomeric ligand (II) diffuses more
slowly into the active site, probably due to the sixth-
position of the isothiocyanate group, once bound, the
xanthonyl portion of the ligand fits into the same slot as
the homologous ligand (I).
Based on the resolved structure of the liganded 4-4-20
active site, the phenylcarboxyl and xanthonyl groups
constituting fluorescein occupy specific subsites (10).
With FITC I bound to the active site the fifth-position on
the phenyl carboxyl group is accommodated through a
spacing that leads to the aqueous phase surrounding the
variable domains. It is apparent that if the isothiocy-
anate group occupies the fifth-position it is favorably
positioned for covalent conjugation with the e-amino
group of lysine H52b (10). However in the case of FITC
II the isothiocyanate group in the sixth-position is
sterically inhibited when bound to the 4-4-20 site. The
latter relates to one of the important features of the
crystal structure of 4-4-20, namely that two residues (Tyr
H53 and Asn L28) form a "lid" over the bound fluo-
rescyl ligand. It would appear that these two residues
assume their position as a consequence of ligand bind-
ing. Conceivably bound FITC (II) may inhibit formation
of the "lid" by residues Tyr H53 and Asn L28 consistent
with the observed iodide accessibility. Establishment of
the "lid" with bound FITC (I) would be consistent with
iodide inaccessibility. Specific formation and location of
the covalent bond upon affinity labeling with FITC (II) is
unclear at this point.
It is now generally accepted that instead of being
rigid, proteins are flexible molecules which dynamically
fluctuate between slightly different conformational sub-
states (21, 22). The existence of variable region confor-
mational substates in antibodies (20) seems a reasonable
extension of this premise and impacts important immu-
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nological phenomena such as affinity and cross-reactiv-
ity. Bound homologous ligand stabilizes a particular
conformer whereas a cross-reacting ligand may stabilize
a different conformer due to structural differences.
Results presented in this manuscript based on the
reactivity of a homogeneous antibody with two isomers
of a hapten are consistent with active site configura-
tional changes and adaptations to accommodate struc-
tural differences in the antigen.
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